WS #13429

From 443 msgs · 9 key-dev

Novo Nordisk beat Q2 estimates with EPS $0.96 vs $0.81 est and revenue $12.209B vs $11.35B est, positive for NVO ahead of Wednesday's earnings.

Novo Nordisk Q2 Beat

Novo Nordisk beat Q2 estimates with EPS $0.96 vs $0.81 est and revenue $12.209B vs $11.35B est, positive for NVO ahead of Wednesday's earnings.

Full world state #13429 →